1. Home
  2. SCPH vs SJT Comparison

SCPH vs SJT Comparison

Compare SCPH & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • SJT
  • Stock Information
  • Founded
  • SCPH 2013
  • SJT 1980
  • Country
  • SCPH United States
  • SJT United States
  • Employees
  • SCPH N/A
  • SJT N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • SJT Oil & Gas Production
  • Sector
  • SCPH Health Care
  • SJT Energy
  • Exchange
  • SCPH Nasdaq
  • SJT Nasdaq
  • Market Cap
  • SCPH 160.6M
  • SJT 212.1M
  • IPO Year
  • SCPH 2017
  • SJT N/A
  • Fundamental
  • Price
  • SCPH $3.28
  • SJT $4.06
  • Analyst Decision
  • SCPH Strong Buy
  • SJT
  • Analyst Count
  • SCPH 2
  • SJT 0
  • Target Price
  • SCPH $15.00
  • SJT N/A
  • AVG Volume (30 Days)
  • SCPH 251.3K
  • SJT 230.2K
  • Earning Date
  • SCPH 03-12-2025
  • SJT 11-14-2024
  • Dividend Yield
  • SCPH N/A
  • SJT 2.33%
  • EPS Growth
  • SCPH N/A
  • SJT N/A
  • EPS
  • SCPH N/A
  • SJT 0.19
  • Revenue
  • SCPH $30,278,000.00
  • SJT $11,031,594.00
  • Revenue This Year
  • SCPH $173.14
  • SJT N/A
  • Revenue Next Year
  • SCPH $131.01
  • SJT N/A
  • P/E Ratio
  • SCPH N/A
  • SJT $21.16
  • Revenue Growth
  • SCPH 303.87
  • SJT N/A
  • 52 Week Low
  • SCPH $3.08
  • SJT $3.21
  • 52 Week High
  • SCPH $6.54
  • SJT $5.81
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 41.79
  • SJT 42.74
  • Support Level
  • SCPH $3.15
  • SJT $4.12
  • Resistance Level
  • SCPH $3.52
  • SJT $4.30
  • Average True Range (ATR)
  • SCPH 0.18
  • SJT 0.19
  • MACD
  • SCPH -0.00
  • SJT -0.04
  • Stochastic Oscillator
  • SCPH 15.22
  • SJT 1.28

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About SJT San Juan Basin Royalty Trust

San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.

Share on Social Networks: